- " TRAVELLER is a global, multicentre, master pre-screening study made to assess potential eligibility for Roche Advert trials, such as Phase III TRONTIER one and a pair of studies evaluating trontinemab in...
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext, image
ImageUnsure
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/a3c83fe6-1ff3-4acf-b37e-0d9b49c4aa1c)